Top

Published in:

01-06-2018 | Case Report

Acute visual loss after botulinum toxin A injection in the masseter muscle

Published in: International Ophthalmology | Issue 3/2018

Abstract

Purpose

Acute visual loss after facial injection of cosmetic materials is rarely reported. In this study, we report one patient who developed acute visual loss after an injection of botulinum toxin A for esthetic purposes.

Methods

A 43-year-old Korean woman presented with a decrease in visual acuity to 20/800 after an injection of botulinum toxin A in the masseter muscle. The visual field testing showed an inferior altitudinal defect, and fluorescein angiography revealed a delayed arm-retinal circulation time.

Results

After intravenous and oral prednisolone was administered, the patient’s visual acuity gradually improved. Two months after the botulinum toxin A injection, the visual acuity had almost returned to baseline, with a remaining paracentral scotoma.

Conclusions

This is the first case of acute visual loss following an injection of botulinum toxin A in a facial lesion. This case emphasizes that the potential risks of botulinum toxin A injection should be considered, and the procedure should be performed delicately.

Lyons CJ, Vickers SF, Lee JP (1990) Botulinum toxin therapy in dysthyroid strabismus. Eye 4(Pt 4):538–542. doi:10.1038/eye.1990.74 CrossRefPubMed

Grazko MA, Polo KB, Jabbari B (1995) Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 45(4):712–717CrossRefPubMed

Klein AW (2004) Contraindications and complications with the use of botulinum toxin. Clin Dermatol 22(1):66–75. doi:10.1016/j.clindermatol.2003.12.026 CrossRefPubMed

Marsh IB (2003) Botulinum toxin and the eye. Hosp Med 64(8):464–467CrossRefPubMed

Korn BS, Seo SW, Levi L, Granet DB, Kikkawa DO (2007) Optic neuropathy associated with botulinum A toxin in thyroid-related orbitopathy. Ophthalmic Plast Reconstr Surg 23(2):109–114. doi:10.1097/IOP.0b013e318032eb12 CrossRefPubMed

Cote TR, Mohan AK, Polder JA, Walton MK, Braun MM (2005) Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 53(3):407–415. doi:10.1016/j.jaad.2005.06.011 CrossRefPubMed

Kalafatis M, Swords NA, Rand MD, Mann KG (1994) Membrane-dependent reactions in blood coagulation: role of the vitamin K-dependent enzyme complexes. Biochem Biophys Acta 1227(3):113–129PubMed

Bevers EM, Comfurius P, Zwaal RF (1993) Mechanisms involved in platelet procoagulant response. Adv Exp Med Biol 344:195–207CrossRefPubMed

Gross S, Tilly P, Hentsch D, Vonesch JL, Fabre JE (2007) Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors. J Exp Med 204(2):311–320. doi:10.1084/jem.20061617 CrossRefPubMedPubMedCentral

10.

Yuzurihara D, Iijima H (2004) Visual outcome in central retinal and branch retinal artery occlusion. Jpn J Ophthalmol 48(5):490–492. doi:10.1007/s10384-004-0102-y CrossRefPubMed

11.

Rumelt S, Brown GC (2003) Update on treatment of retinal arterial occlusions. Curr Opin Ophthalmol 14(3):139–141CrossRefPubMed

12.

Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE (2004) Macular edema. Surv Ophthalmol 49(5):470–490. doi:10.1016/j.survophthal.2004.06.002 CrossRefPubMed

13.

Williamson TH, O’Donnell A (2005) Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Am J Ophthalmol 139(5):860–866. doi:10.1016/j.ajo.2005.01.001 CrossRefPubMed

14.

Cunningham MA, Edelman JL, Kaushal S (2008) Intravitreal steroids for macular edema: the past, the present, and the future. Surv Ophthalmol 53(2):139–149. doi:10.1016/j.survophthal.2007.12.005 CrossRefPubMed

Title: Acute visual loss after botulinum toxin A injection in the masseter muscle
Publication date: 01-06-2018
Published in: International Ophthalmology / Issue 3/2018
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-017-0569-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Acute visual loss after botulinum toxin A injection in the masseter muscle

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2018

Comparison of immediate versus deferred intravitreal Bevacizumab in macular oedema due to branch retinal vein occlusion: a pilot study

Fine mapping of chromosome 9 locus associated with congenital cataract

Clinical and genetic analysis of Indian patients with NDP-related retinopathies

Topography and correlation of radial peripapillary capillary density network with retinal nerve fibre layer thickness

In vitro optical quality of monofocal aspheric toric intraocular lenses: effect of cylindrical power

Comparison of visual outcomes and reading performance after bilateral implantation of multifocal intraocular lenses with bilateral monofocal intraocular lenses